AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10447324 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 7818105 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide anesthesia
Number of subjects: 60
Study 7818105 — intervention group
Group type: COMPARATOR
Intervention: No nitrous oxide anesthesia (control group)
Number of subjects: 60
Study 1708037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8654
Study 372858 — intervention group
Group type: EXPERIMENTAL
Intervention: gamma-ethylester of glutamic acid (25 g)
Number of subjects: 45
Study 372858 — intervention group
Group type: EXPERIMENTAL
Intervention: l-arginine (25 g)
Number of subjects: 45
Study 372858 — intervention group
Group type: COMPARATOR
Intervention: placebo (physiological solution in identical 500 ml bottles)
Number of subjects: 45
Study 31915052 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care ultrasound (POCUS)
Number of subjects: 250
Study 31915052 — intervention group
Group type: COMPARATOR
Intervention: No POCUS (control group)
Number of subjects: 250
Study 30371811 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy (transfuse hemoglobin <7 g/dL) in massive burns
Number of subjects: 345
Study 30371811 — intervention group
Group type: COMPARATOR
Intervention: Liberal transfusion strategy (transfuse hemoglobin <10 g/dL) in massive burns
Number of subjects: 345
Study 30371811 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy in major burns
Number of subjects: 345
Study 30371811 — intervention group
Group type: COMPARATOR
Intervention: Liberal transfusion strategy in major burns
Number of subjects: 345
Study 29734777 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunrouge extract containing 11.2 mg anthocyanin and 323.6 mg EGCG
Number of subjects: 120
Study 29734777 — intervention group
Group type: EXPERIMENTAL
Intervention: Yabukita extract containing 322.2 mg EGCG
Number of subjects: 120
Study 29734777 — intervention group
Group type: COMPARATOR
Intervention: Placebo group receiving barley extract without catechin
Number of subjects: 120
Study 26887587 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal midazolam
Number of subjects: 0
Study 26887587 — intervention group
Group type: COMPARATOR
Intervention: Intranasal placebo
Number of subjects: 0
Study 24941177 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg
Number of subjects: 958
Study 24941177 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg
Number of subjects: 958
Study 24941177 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 958
Study 21805328 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate (160 mg daily for up to 6 months)
Number of subjects: 32
Study 21805328 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 32
Study 19440700 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 g/kg ethanol
Number of subjects: 40
Study 19440700 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 40
Study 17456652 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.0625 mg/kg
Number of subjects: 125
Study 17456652 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.125 mg/kg
Number of subjects: 125
Study 17456652 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.25 mg/kg
Number of subjects: 125
Study 17456652 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.5 mg/kg
Number of subjects: 125
Study 17456652 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 1.0 mg/kg
Number of subjects: 125
Study 17456652 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (all doses)
Number of subjects: 125
Study 15178381 — intervention group
Group type: EXPERIMENTAL
Intervention: Inductive reasoning tasks
Number of subjects: 16
Study 15178381 — intervention group
Group type: EXPERIMENTAL
Intervention: Deductive reasoning tasks
Number of subjects: 16
Study 15178381 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasoning Type (deduction and induction) by Task (reasoning and baseline) interaction
Number of subjects: 16
Study 11508019 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional attire
Number of subjects: 38
Study 11508019 — intervention group
Group type: COMPARATOR
Intervention: Casual attire
Number of subjects: 38
Study 9241003 — intervention group
Group type: EXPERIMENTAL
Intervention: Brofaromine (50 mg/day titrated to 150 mg/day)
Number of subjects: 102
Study 9241003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 8390340 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin releasing hormone agonist (GnRHA) with low doses of oral estrogen (0.625 mg conjugated estrogen, CE for 6 days/week) and intermittent oral progestogen (10 mg medroxyprogesterone acetate, MPA for 13 days every 4 months)
Number of subjects: 18
Study 8390340 — intervention group
Group type: COMPARATOR
Intervention: Control arm (not specified)
Number of subjects: 18
Study 2892259 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine (150 mg h.s.)
Number of subjects: 513
Study 2892259 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 513
Study 31072380 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous mesenchymal stem cells (MSC) treatment
Number of subjects: 0
Study 31072380 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26938761 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency thermocoagulation (RFTC)
Number of subjects: 54
Study 26938761 — intervention group
Group type: COMPARATOR
Intervention: Regular treatments (Control)
Number of subjects: 54
Study 26938761 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Cases and Controls)
Number of subjects: 54
Study 24903908 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-week resistance-type exercise training
Number of subjects: 100
Study 24903908 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 100
Study 24161413 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cholera vaccine (Shanchol™), two doses
Number of subjects: 172754
Study 24161413 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine plus safe water and hand washing practice
Number of subjects: 172754
Study 24161413 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 172754
Study 21276188 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture
Number of subjects: 45
Study 21276188 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical acupuncture
Number of subjects: 45
Study 21276188 — intervention group
Group type: COMPARATOR
Intervention: Nonpenetrating sham acupuncture (NPSA) with simulated manual stimulation
Number of subjects: 45
Study 21276188 — intervention group
Group type: COMPARATOR
Intervention: Nonpenetrating sham acupuncture (NPSA) with simulated electrical stimulation
Number of subjects: 45
Study 19451353 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (402 mg every other day)
Number of subjects: 2824
Study 19451353 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta carotene (50 mg every other day)
Number of subjects: 2824
Study 19451353 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg daily)
Number of subjects: 2824
Study 16756056 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinott‐P (generic clindamycin)
Number of subjects: 24
Study 16756056 — intervention group
Group type: COMPARATOR
Intervention: Dalacin C (original preparation)
Number of subjects: 24
Study 16756056 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Clinott‐P and Dalacin C
Number of subjects: 24
Study 15531858 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/day oral isoflavones
Number of subjects: 60
Study 15531858 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg/day oral isoflavones
Number of subjects: 60
Study 15531858 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg/day transdermal isoflavones
Number of subjects: 60
Study 15531858 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg/day transdermal isoflavones
Number of subjects: 60
Study 15531858 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60
Study 11745230 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI)
Number of subjects: 52
Study 11745230 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous ethanol injection (PEI) alone
Number of subjects: 52
Study 11745230 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with TACE-PEI
Number of subjects: 52
Study 11745230 — intervention group
Group type: COMPARATOR
Intervention: PEI alone
Number of subjects: 52
Study 11745230 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with TACE-PEI (for tumors < 2 cm)
Number of subjects: 52
Study 11745230 — intervention group
Group type: COMPARATOR
Intervention: PEI alone (for tumors < 2 cm)
Number of subjects: 52
Study 8976640 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular methyl prednisolone acetate
Number of subjects: 59
Study 8976640 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 1420751 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg
Number of subjects: 342
Study 1420751 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg
Number of subjects: 342
Study 1420751 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 342
Study 6363216 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection sclerotherapy at intervals of one week
Number of subjects: 55
Study 6363216 — intervention group
Group type: COMPARATOR
Intervention: Injection sclerotherapy at intervals of three weeks
Number of subjects: 55
Study 31842811 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal dose of radical radiotherapy (using PIBS point system)
Number of subjects: 936
Study 30232662 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquefied petroleum gas (LPG) stoves
Number of subjects: 200
Study 27084856 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group (final abutment placed and tightened to 30 Ncm)
Number of subjects: 0
Study 27084856 — intervention group
Group type: COMPARATOR
Intervention: Control group (healing abutment)
Number of subjects: 0
Study 25243962 — intervention group
Group type: EXPERIMENTAL
Intervention: Fufang Biejia Ruangan Tablet plus entecavir (Group A, n=56)
Number of subjects: 163
Study 25243962 — intervention group
Group type: COMPARATOR
Intervention: Entecavir only (Group B, n=52)
Number of subjects: 163
Study 25243962 — intervention group
Group type: COMPARATOR
Intervention: Fufang Biejia Ruangan tablet only (Group C, n=55)
Number of subjects: 163
Study 22007735 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation (PNF) techniques (rhythmic initiation, dynamic reversion, isotonic combination)
Number of subjects: 15
Study 22007735 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation (PNF) techniques
Number of subjects: 15
Study 20448634 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Aerobic Interval Training (AIT)
Number of subjects: 44
Study 20448634 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise Training (CMT)
Number of subjects: 44
Study 20448634 — intervention group
Group type: COMPARATOR
Intervention: Control group (ConFH+)
Number of subjects: 44
Study 20448634 — intervention group
Group type: COMPARATOR
Intervention: Control group (ConFH-)
Number of subjects: 44
Study 18931237 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 0
Study 18931237 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 0
Study 18931237 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 0
Study 16093743 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with FMS
Number of subjects: 105
Study 16093743 — intervention group
Group type: EXPERIMENTAL
Intervention: Women who reported rape
Number of subjects: 105
Study 16093743 — intervention group
Group type: COMPARATOR
Intervention: Control group (no FMS)
Number of subjects: 105
Study 12131110 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (1,200 mg)
Number of subjects: 25
Study 12131110 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 10080511 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily vigabatrin administration
Number of subjects: 50
Study 10080511 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily vigabatrin administration
Number of subjects: 50
Study 7743571 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 MAC HAL-N2O
Number of subjects: 24
Study 7743571 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 MAC HAL-N2O
Number of subjects: 24
Study 7743571 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 MAC ISO-N2O
Number of subjects: 24
Study 7743571 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 MAC ISO-N2O
Number of subjects: 24
Study 1559299 — intervention group
Group type: EXPERIMENTAL
Intervention: Biosynthetic growth hormone (GH) for 6 months
Number of subjects: 14
Study 1559299 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 14
Study 3876763 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity recall in a randomized, one-year exercise trial
Number of subjects: 0
Study 3876763 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity recall in two worksite health promotion projects
Number of subjects: 0
Study 30531205 — intervention group
Group type: EXPERIMENTAL
Intervention: Shift-and-persist psychological strategy
Number of subjects: 645
Study 30531205 — intervention group
Group type: EXPERIMENTAL
Intervention: Shifting and persisting as separate variables
Number of subjects: 645
Study 30587235 — intervention group
Group type: EXPERIMENTAL
Intervention: SBIRT toolkit implementation
Number of subjects: 2562
Study 30587235 — intervention group
Group type: COMPARATOR
Intervention: Usual care (wait-list control)
Number of subjects: 2562
Study 30587235 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse surveys on smoking cessation activities
Number of subjects: 2562
Study 30587235 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse surveys on SBIRT use
Number of subjects: 2562
Study 30587235 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline capacity assessment and implementation fidelity survey
Number of subjects: 2562
Study 30587235 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured interview with site coordinators
Number of subjects: 2562
Study 27233465 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuro-retinal rim area (NRA) measurement in glaucoma subjects
Number of subjects: 56
Study 27233465 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuro-retinal rim area (NRA) measurement in healthy subjects
Number of subjects: 56
Study 27233465 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up of glaucoma progression using NRA measurement
Number of subjects: 56
Study 23361591 — intervention group
Group type: EXPERIMENTAL
Intervention: Histidine supplementation (4 g/day for 12 weeks)
Number of subjects: 100
Study 23361591 — intervention group
Group type: COMPARATOR
Intervention: Placebo (4 g/day for 12 weeks)
Number of subjects: 100
Study 21987912 — intervention group
Group type: EXPERIMENTAL
Intervention: Sport stacking
Number of subjects: 32
Study 21987912 — intervention group
Group type: COMPARATOR
Intervention: Arts/crafts
Number of subjects: 32
Study 19845233 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha tocopherol (525 IU) administered orally at 48 hr, 24 hr, and in the morning prior to coronary procedures
Number of subjects: 103
Study 19845233 — intervention group
Group type: COMPARATOR
Intervention: Placebo compound administered orally at 48 hr, 24 hr, and in the morning prior to coronary procedures
Number of subjects: 103
Study 16895709 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/d)
Number of subjects: 1255
Study 16895709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1255
Study 15055365 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye gaze cue
Number of subjects: 0
Study 15055365 — intervention group
Group type: EXPERIMENTAL
Intervention: Arrow cue
Number of subjects: 0
Study 15055365 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued targets
Number of subjects: 0
Study 15055365 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled attention
Number of subjects: 0
Study 11340314 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold water stimuli (10-12 degrees C) applied as a Kneipp face shower for 10 seconds followed by a cold wet pack at the neck for 1 minute.
Number of subjects: 24
Study 11340314 — intervention group
Group type: COMPARATOR
Intervention: Warm water stimuli (34-36 degrees C) applied identically to cold stimuli.
Number of subjects: 24
Study 9404414 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure measurements taken by a cardiologist (specialist)
Number of subjects: 180
Study 9404414 — intervention group
Group type: COMPARATOR
Intervention: Blood pressure measurements taken by training doctors (six doctors in training)
Number of subjects: 180
Study 8200011 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg/day + omega-3 polyunsaturated fatty acids (n3-PUFA)
Number of subjects: 39
Study 8200011 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 10 mg/day
Number of subjects: 39
Study 3709642 — intervention group
Group type: EXPERIMENTAL
Intervention: sublingual isosorbide dinitrate (ISDN) 5 mg
Number of subjects: 12
Study 3709642 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 28717981 — intervention group
Group type: EXPERIMENTAL
Intervention: Education- and strengths-based counselling programme (three sessions) incorporated into routine clinic visits.
Number of subjects: 519
Study 28717981 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control).
Number of subjects: 519
Study 27664531 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-compassion meditation training
Number of subjects: 80
Study 27664531 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 80
Study 24785951 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive pills
Number of subjects: 1785
Study 24785951 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable contraception
Number of subjects: 1785
Study 24785951 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal implants
Number of subjects: 1785
Study 24785951 — intervention group
Group type: COMPARATOR
Intervention: No contraception
Number of subjects: 1785
Study 22730912 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT) with methylene blue 450 μg/mL and low-power laser
Number of subjects: 21
Study 22730912 — intervention group
Group type: COMPARATOR
Intervention: Low-level laser therapy (LLLT) with wavelength 660 nm, power of 30 mW, fluence of 7.5 J/cm(2)
Number of subjects: 21
Study 22730912 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole 100 mg/day for 14 days
Number of subjects: 21
Study 20970760 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured aerobic exercise regimen (weekly supervised exercise sessions over a 10-week period, including education, warm-up, 30 minutes of aerobic exercise, and cool down, with exercise intensity adjusted to reach a heart rate goal of 60% of the participant's estimated maximal heart rate)
Number of subjects: 0
Study 20970760 — intervention group
Group type: EXPERIMENTAL
Intervention: High-activity group (exercising ≥ 90 minutes per week)
Number of subjects: 0
Study 20970760 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-activity group (exercising < 90 minutes per week)
Number of subjects: 0
Study 20970760 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study 18563970 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to 'Rhapsody on a Theme of Paganini, Op. 43, Variation 18' by Rachmaninoff using a Continuous Response Digital Interface (CRDI) dial.
Number of subjects: 60
Study 18563970 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to 'Rhapsody on a Theme of Paganini, Op. 43, Variation 18' by Rachmaninoff.
Number of subjects: 60
Study 18563970 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparative analysis based on developmental statuses (normally developing, gifted, special needs).
Number of subjects: 60
Study 16001382 — intervention group
Group type: EXPERIMENTAL
Intervention: Anecortave acetate 15 mg for depot suspension
Number of subjects: 128
Study 16001382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 12471300 — intervention group
Group type: EXPERIMENTAL
Intervention: Euhydrated hot (EH)
Number of subjects: 10
Study 12471300 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydrated hot (DH)
Number of subjects: 10
Study 12471300 — intervention group
Group type: COMPARATOR
Intervention: Euhydrated neutral (EN)
Number of subjects: 10
Study 12471300 — intervention group
Group type: COMPARATOR
Intervention: Dehydrated neutral (DN)
Number of subjects: 10
Study 10601917 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginally administered moistened misoprostol tablets (800 microg, repeated 24 hours later if needed)
Number of subjects: 200
Study 10601917 — intervention group
Group type: COMPARATOR
Intervention: Mifepristone (600 mg) followed by oral misoprostol (400 microg)
Number of subjects: 200
Study 10601917 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginally administered moistened misoprostol tablets
Number of subjects: 200
Study 10601917 — intervention group
Group type: COMPARATOR
Intervention: Mifepristone and oral misoprostol
Number of subjects: 200
Study 10601917 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study 7793544 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg
Number of subjects: 118
Study 7793544 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 118
Study 7793544 — intervention group
Group type: COMPARATOR
Intervention: metoclopramide 10 mg
Number of subjects: 118
Study 7793544 — intervention group
Group type: COMPARATOR
Intervention: droperidol 1 mg
Number of subjects: 118
Study 2074205 — intervention group
Group type: EXPERIMENTAL
Intervention: Retransfusion of shed mediastinal blood
Number of subjects: 20